Recognition underscores the potential of OCRA’s innovative approach to accelerating gynecologic cancer research through AI, data sharing, and collaboration.
Amazon Web Services (AWS) has launched its Health Impact Initiative, a $100 million, five-year commitment to putting AI, advanced computing, and cloud infrastructure in the hands of organizations working to address some of the world’s most pressing health challenges. OCRA’s Community Accelerated Research Exchange (Research Exchange) is among the innovative efforts highlighted in the announcement.

In his announcement of the initiative, Dr. Rowland Illing, Chief Medical Officer and Director of Healthcare and Life Sciences at AWS, points to OCRA as an example of work helping to close longstanding gaps in women’s health research. He notes that OCRA has “developed a global federated research network to accelerate research in gynecologic cancers.”
Changing how research gets done
We’re not simply trying to fund more research,” said Audra Moran, President and CEO of OCRA. “We’re working to fundamentally change how research gets done.
For too long, cancer research has been constrained by fragmented data, institutional silos, and valuable scientific information that remains inaccessible or underutilized.
OCRA’s Research Exchange is designed to address these barriers by connecting patients, researchers, scientific datasets, and advanced analytical tools in a collaborative, AI-enabled research ecosystem. AWS is supporting this work with cloud computing resources that help power the infrastructure needed to accelerate discovery and advance research toward better patient outcomes.
The Research Exchange includes two interconnected components:
Discovery Lab is an AI-enabled Trusted Research Environment (TRE) where researchers can securely explore datasets, use advanced analytical tools, and collaborate across institutions and disciplines. It is designed to make valuable research data more accessible while maintaining appropriate privacy and security protections.
Living Lab is a national patient registry for ovarian and uterine cancers that enables patients and survivors to contribute health information, treatment experiences, and quality-of-life insights over time. These contributions help researchers better understand the diseases, identify important questions, and accelerate the development of improved approaches to prevention, diagnosis, and treatment.
When the Research Exchange launched in May 2026, Dr. Illing described it as “a lighthouse project for demonstrating how cloud and generative AI technologies can support innovation in healthcare at a global scale.”
AWS’s support is helping us turn that vision into reality,” said Moran. “I’m grateful to Dr. Illing and the entire AWS team for recognizing the potential of this work and for their extraordinary commitment to advancing women’s health. This is an exciting step toward changing the future of gynecologic cancer.